secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moderna, Inc. (MRNA)
CIK:        0001682852
Form:       8-K
Filed at:   2026-07-08T11:08:16+00:00
Accession:  0001682852-26-000134
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moderna appoints former Biogen CFO Michael McDonnell to Board of Directors
--------------------------------------------------------------------------

- Michael McDonnell appointed to Moderna's Board, effective July 8, 2026; will serve on Audit Committee.
- McDonnell served as Biogen CFO from Aug 2020 to Feb 2025; also CFO of IQVIA, Intelsat, MCG Capital, EchoStar.
- David Rubenstein moved off Audit Committee to Nominating and Corporate Governance Committee.
- McDonnell will receive standard non-employee director compensation including initial and pro-rata annual grants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1682852/000168285226000134/0001682852-26-000134-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1682852/000168285226000134/mrna-20260706.htm
  HTML page:      https://secwatch.observer/filing/0001682852-26-000134

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer